EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A medium chain fatty acid, 6-hydroxyhexanoic acid (6-HHA), protects against obesity and insulin resistance

Sara C Sebag, Meihua Hao, Qingwen Qian, Chawin Upara, Qiong Ding, Min Zhu, Jeffrey A Banas, Huojun Cao, Liu Hong, Ling Yang

Acta Pharmaceutica Sinica B · 2024-04 · 14 (4) · 1892-1894

DOI: 10.1016/j.apsb.2024.01.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2024-04. Verfasst von Sara C Sebag und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Cell Biology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity, a worldwide health problem, increases the risk for developing metabolic diseases such as insulin resistance and diabetes. It is well recognized that obesity-associated chronic inflammation plays a key role in the pathogenesis of systemic metabolic dysfunction. Previously, we revealed an anti-inflammatory role for spent culture supernatants isolated from the oral commensal bacterial species Streptococcus gordonii (Sg-SCS). Here, we identified that 6-hydroxyhexanoic acid (6-HHA), a medium chain fatty acid (MCFA), is the one of the key components of Sg-SCS . We found that treatment of 6-HHA in mice fed a high-fat diet (HFD) significantly reduced HFD-mediated weight gain which was largely attributed to a decrease in fat mass. Systemically, 6-HHA improves obesity-associated glucose intolerance and insulin resistance. Furthermore, administration of 6-HHA suppressed obesity-associated systemic inflammation and dyslipidemia. At the cellular level, treatment of 6-HHA ameliorated aberrant inflammatory and metabolic transcriptomic signatures in white adipose tissue of mice with diet-induced obesity (HFD). Mechanistically, we found that 6-HHA suppressed adipocyte-proinflammatory cytokine production and lipolysis, the latter through Gαi-mediated signaling. This work provides direct evidence for the anti-obesity effects of a novel MCFA, which could be a new therapeutic treatment for combating obesity. KEY POINTS Hydroxyhexanoic medium chain fatty acids (MCFAs) are dietary and bacterial-derived energy sources, however, the outcomes of using MCFAs in treating metabolic disorders are diverse and complex. The MCFA 6-hydroxyhexanoic acid (6-HHA) is a metabolite secreted by the oral bacterial commensal species Streptococcus gordonii; here we investigated its role in modulating high-fat diet (HFD)-induced metabolic dysfunction. In a murine model of obesity, we found 6-HHA-mediated improvement of diet-mediated adiposity, insulin resistance and inflammation were in part due to actions on white adipose tissue (WAT). 6-HHA suppressed proinflammatory cytokine production and lipolysis through Gi-mediated signaling in differentiated white adipocytes.

Schlagwörter

Stichwörter der Autor:innen

6-Hydroxyhexanoic acidAdipose lipolysisInsulin resistanceObesity

Autor:innen und Institutionen

  • Department of Anatomy and Cell Biology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.
  • Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.
  • Pappajohn Biomedical Institute, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.
  • Iowa Institute for Oral Health Research, University of Iowa College of Dentistry, Iowa City, IA 52242, USA.

Förderung

  • NIDDK NIH HHS
  • NIDCR NIH HHS

Zitieren

APA

Sebag, S. C., Hao, M., Qian, Q., Upara, C., Ding, Q., Zhu, M., Banas, J. A., Cao, H., Hong, L., & Yang, L. (2024). A medium chain fatty acid, 6-hydroxyhexanoic acid (6-HHA), protects against obesity and insulin resistance. Acta Pharmaceutica Sinica B, 14(4), 1892-1894. https://doi.org/10.1016/j.apsb.2024.01.002

Vancouver

Sebag SC, Hao M, Qian Q, Upara C, Ding Q, Zhu M, et al. A medium chain fatty acid, 6-hydroxyhexanoic acid (6-HHA), protects against obesity and insulin resistance. Acta Pharmaceutica Sinica B. 2024;14(4):1892-1894. doi:10.1016/j.apsb.2024.01.002

BibTeX
@article{Sebag2024,
  author = {Sebag, Sara C and Hao, Meihua and Qian, Qingwen and Upara, Chawin and Ding, Qiong and Zhu, Min and Banas, Jeffrey A and Cao, Huojun and Hong, Liu and Yang, Ling},
  title = {A medium chain fatty acid, 6-hydroxyhexanoic acid (6-HHA), protects against obesity and insulin resistance},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2024},
  volume = {14},
  number = {4},
  pages = {1892--1894},
  doi = {10.1016/j.apsb.2024.01.002}
}
Kostenlos starten →